SONM Earnings

Quarterly EPS
$-25.38
Q2 2024
$-9.32
Q3 2024
$-79.40
Q4 2024
$1.41
Q1 2025
$-14.22
Q2 2025
$-4.83
Q3 2025
$-8.44
Q4 2025
$5.01
Q1 2026
Latest RevenueN/A
Latest Net Income6.3M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2026$5.016.3M+255.3%
Q4 2025-$8.44-8887000+89.4%
Q3 2025-$4.8316.2M-4753000+7.9%+48.2%
Q2 2025-$14.2211.2M-7475000-2.8%+44.0%
Q1 2025$1.41458.0K+112.1%
Q4 2024-$79.4015.0M-21614000+11.6%-1,378.6%
Q3 2024-$9.3215.0M-2512000-45.5%-531.5%
Q2 2024-$25.3811.5M-6616000-57.1%-1,275.0%
Q1 2024-$11.7016.8M-2906000
Q4 2023-$5.3713.4M-1353000
Q3 2023$2.1627.6M527.0K
Q2 2023$2.1626.8M509.0K
DNA X (SONM) — Earnings